Conclusions
depression, acute stroke, depressive symptoms
ACUTE STROKE
ACT is effective in treating acute stroke patients with depression, and the efficacy was maintained at 3‐month follow‐up.This study found that G‐ACT could significantly reduce depressive symptoms in patients with acute stroke, and the interventional efficacy was maintained at 3‐month follow‐up (partial Ƞ2 for this effect was 0.306), with similar benefits being observed for HRQoL‐MCS, sleep quality, psychological flexibility, cognitive fusion, and confidence, and that G‐ACT can be performed well by clinical nurses with sufficient training and support.

